Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

J. Lederhofer, J. van Lent, F. Bhoelan, Z. Karneva, A. de Haan, J.C. Wilschut, T. Stegmann*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences